195 filings
Page 6 of 10
8-K
b5pb619 lo4
7 Jul 20
Other Events
7:28am
8-K
qnasl wx8tpz2ji6iiv0
19 Jun 20
Biocardia Announces Pricing of $10 Million Public Offering
5:09pm
8-K
caj90bd4ove3vuj21zvw
8 May 20
Entry into a Material Definitive Agreement
6:02am
8-K
olggxv4l gr8a1vu
6 May 20
BioCardia Announces Positive Preclinical Results Supporting Investigational New Drug Application for Anti-Inflammatory Cell Therapy in Heart Failure
12:00am
8-K
t68fmjq
28 Apr 20
Departure of Directors or Certain Officers
4:15pm
8-K
n0d489s4
21 Apr 20
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:17pm
8-K
8yu6i5mtgqv4r
14 Apr 20
Entry into a Material Definitive Agreement
7:30am
8-K
e5h pr058lovb9d
29 Nov 19
Submission of Matters to a Vote of Security Holders
7:29am
8-K
rn9g154 y89acnn43d
6 Nov 19
Other Events
7:11am
8-K
0or1 imxocs379ex73
27 Sep 19
Departure of Directors or Certain Officers
4:25pm
8-K
30v8wwojq
17 Sep 19
Biocardia Announces Positive DSMB Recommendation to Continue Phase 3 Pivotal Cardiamp Heart Failure Study As Planned
4:42pm
8-K
zser5blf3 sc
30 Aug 19
Termination of a Material Definitive Agreement
4:02pm
8-K
gubq2brv
7 Aug 19
Biocardia Announces Pricing of $10.0 Million Public Offering and Uplisting to Nasdaq
12:00am
8-K
6lt5qtidhpv1dm9iak7
5 Jul 19
Entry into a Material Definitive Agreement
12:48pm
8-K
b8767er3bpm ok
7 Jun 19
Biocardia Announces Reverse Stock Split and Plan for Listing on a Major Stock Exchange
6:08am
8-K
nbkyk2dj71tmugr ff9s
9 May 19
Biocardia Receives Fda Clearance for Avance Steerable Introducer for Transseptal Access to Heart
12:00am
8-K
6xeiv 1pqezd
22 Apr 19
Regulation FD Disclosure
7:39am
8-K
kchu7ev
4 Feb 19
Regulation FD Disclosure
7:33am
8-K
01roa4gdqkrjejux1icr
27 Dec 18
Entry into a Material Definitive Agreement
3:33pm
8-K
c9b pr13h47s8i
11 Dec 18
Other Events
8:34am